Cargando…
Reply to Retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911203/ https://www.ncbi.nlm.nih.gov/pubmed/32634899 http://dx.doi.org/10.1093/annonc/mdq329 |
| _version_ | 1782184448903610368 |
|---|---|
| author | Foley, K. A. Song, X. |
| author_facet | Foley, K. A. Song, X. |
| author_sort | Foley, K. A. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2911203 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-29112032010-08-01 Reply to Retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns Foley, K. A. Song, X. Ann Oncol Letters to the Editor Oxford University Press 2010-08 /pmc/articles/PMC2911203/ /pubmed/32634899 http://dx.doi.org/10.1093/annonc/mdq329 Text en © The Author 2010. Published by Oxford University Press on behalf of the European Society for Medical Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Foley, K. A. Song, X. Reply to Retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns |
| title | Reply to Retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns |
| title_full | Reply to Retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns |
| title_fullStr | Reply to Retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns |
| title_full_unstemmed | Reply to Retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns |
| title_short | Reply to Retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns |
| title_sort | reply to retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911203/ https://www.ncbi.nlm.nih.gov/pubmed/32634899 http://dx.doi.org/10.1093/annonc/mdq329 |
| work_keys_str_mv | AT foleyka replytoretrospectiveevaluationofcetuximabrelatedadverseeventsfromclaimsdatabasesmethodologicalconcerns AT songx replytoretrospectiveevaluationofcetuximabrelatedadverseeventsfromclaimsdatabasesmethodologicalconcerns |